Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track FBIOP with free AI briefings, catalyst countdowns, and dilution alerts.

FBIOP · Fortress Biotech, Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$152.2M Cash on Hand
13.9mo Cash Runway
Follow FBIOP by email Get an email when FBIOP reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about FBIOP, unsubscribe in one click. Privacy

📣 What FBIOP Says Is Next

Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

💰 Cash Runway & Dilution Risk

FBIOP holds $152.2M in cash and short-term investments (as of Sep 30, 2026) and burns about $32.7M/quarter from operations, an estimated runway of 13.9 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 57 · Elevated

Recent financing filings on SEC EDGAR:

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when FBIOP files for a raise →

👥 Who Owns FBIOP

Insiders 11.8% Other 5%+ holders 11% Institutions 3.3% Public and other holders 73.9%
HolderTypeShares% of sharesAs of
Lindsay A. Rosenwald, M.D. 5%+ holder (13D) 6,917,715 8.39% 2026-03-18
Lindsay A Md Rosenwald
PRESIDENT, CEO & CHAIRMAN, Director, 10% · +763,359 options
Insider 4,586,841 5.56% 2026-03-18
Highbridge Capital Management, LLC Institution (13G, 5%+) 2,734,654 3.32% 2026-03-31
Michael S Weiss
Executive Vice Chairman, Director
Insider 2,276,562 2.76% 2026-03-18
Millennium Management LLC 5%+ holder (13G) 2,165,401 2.63% 2026-09-30
David Jin
Chief Financial Officer
Insider 1,652,761 2.00% 2026-10-01
Fortress Biotech, Inc.
10% owner
Insider 439,733 0.53% 2026-01-02
J Jay Lobell
Director
Insider 192,397 0.23% 2026-01-01
Jimmie Harvey
Director
Insider 146,704 0.18% 2026-01-01
Dov Klein
Director
Insider 130,105 0.16% 2026-01-01
Malcolm Hoenlein
Director
Insider 115,747 0.14% 2026-01-01
Kevin Lorenz
Director
Insider 101,009 0.12% 2026-01-01

Share count 82,474,127 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the largest 13F holders. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full FBIOP picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for FBIOP and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.